On other hand, alteration on the Epidermal Growth Factor Receptor (EGFR) gene is found in 15% of lung adenocarcinoma and translocations of the Anaplastic Lymphoma Kinase (ALK) gene occur in 3%-7% of lung adenocarcinoma [41]. This evidence concerns the gene EGFR and lung adenocarcinoma.